Literature DB >> 35293183

[Research progress of traumatic heterotopic ossification].

Guorui Cao1,2, Fuxing Pei2.   

Abstract

Objective: To review and evaluate the research progress of traumatic heterotopic ossification (HO).
Methods: The domestic and foreign related research literature on traumatic HO was widely consulted, and its etiology, pathogenesis, pathological progress, diagnosis, prevention, and treatment were summarized.
Results: Traumatic HO is often caused by severe trauma such as joint operation, explosion injury, nerve injury, and burn. At present, it is widely believed that the occurrence of traumatic HO is closely related to inflammation and hypoxia. Oral non-steroidal anti-inflammatory drugs and surgery are the main methods to prevent and treat traumatic HO.
Conclusion: Nowadays, the pathogenesis of traumatic HO is still unclear, the efficiency of relevant prevention and treatment measures is low, and there is a lack of specific treatment method. In the future, it is necessary to further study the pathogenesis of traumatic HO and find specific prevention and treatment targets.

Entities:  

Keywords:  Heterotopic ossification; explosion injury; inflammation; muscle injury

Mesh:

Year:  2022        PMID: 35293183      PMCID: PMC8923934          DOI: 10.7507/1002-1892.202110078

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  92 in total

Review 1.  Heterotopic Ossification: Basic-Science Principles and Clinical Correlates.

Authors:  Kavitha Ranganathan; Shawn Loder; Shailesh Agarwal; Victor W Wong; Victor C Wong; Jonathan Forsberg; Thomas A Davis; Stewart Wang; Aaron W James; Benjamin Levi
Journal:  J Bone Joint Surg Am       Date:  2015-07-01       Impact factor: 5.284

2.  Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.

Authors:  Shailesh Agarwal; Shawn Loder; Cameron Brownley; David Cholok; Laura Mangiavini; John Li; Christopher Breuler; Hsiao H Sung; Shuli Li; Kavitha Ranganathan; Joshua Peterson; Ronald Tompkins; David Herndon; Wenzhong Xiao; Dolrudee Jumlongras; Bjorn R Olsen; Thomas A Davis; Yuji Mishina; Ernestina Schipani; Benjamin Levi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

3.  Heterotopic ossification revisited.

Authors:  Andreas F Mavrogenis; Panayotis N Soucacos; Panayiotis J Papagelopoulos
Journal:  Orthopedics       Date:  2011-03-11       Impact factor: 1.390

4.  Multi-center observational study on occurrence and related clinical factors of neurogenic heterotopic ossification in patients with disorders of consciousness.

Authors:  A Estraneo; A Pascarella; O Masotta; M Bartolo; F Pistoia; C Perin; S Marino; L Lucca; V Pingue; E Casanova; A M Romoli; S Gentile; R Formisano; G P Salvi; F Scarponi; A De Tanti; P Bongioanni; E Rossato; A Santangelo; A R Diana; M Gambarin; D Intiso; R Antenucci; S Premoselli; M Bertoni; L Trojano
Journal:  Brain Inj       Date:  2021-03-18       Impact factor: 2.311

5.  Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model.

Authors:  Eric Rodenberg; Ali Azhdarinia; ZaWaunyka W Lazard; Mary Hall; Sun Kuk Kwon; Nathaniel Wilganowski; Elizabeth A Salisbury; Maria Merched-Sauvage; Elizabeth A Olmsted-Davis; Eva M Sevick-Muraca; Alan R Davis
Journal:  Tissue Eng Part A       Date:  2011-08-02       Impact factor: 3.845

6.  Transcutaneous Raman spectroscopy of murine bone in vivo.

Authors:  Matthew V Schulmerich; Jacqueline H Cole; Jaclynn M Kreider; Francis Esmonde-White; Kathryn A Dooley; Steven A Goldstein; Michael D Morris
Journal:  Appl Spectrosc       Date:  2009-03       Impact factor: 2.388

7.  Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model.

Authors:  S M Zimmermann; C C Würgler-Hauri; G A Wanner; H P Simmen; C M L Werner
Journal:  Injury       Date:  2013-02-08       Impact factor: 2.586

8.  Evaluation of Salivary Cytokines for Diagnosis of both Trauma-Induced and Genetic Heterotopic Ossification.

Authors:  Hsiao Hsin Sung Hsieh; Michael T Chung; Ronald M Allen; Kavitha Ranganathan; Joe Habbouche; David Cholok; Jonathan Butts; Arminder Kaura; Ramkumar Tiruvannamalai-Annamalai; Chris Breuler; Caitlin Priest; Shawn J Loder; John Li; Shuli Li; Jan Stegemann; Steven L Kunkel; Benjamin Levi
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

9.  TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways.

Authors:  Fátima Guerrero; Carmen Herencia; Yolanda Almadén; Julio M Martínez-Moreno; Addy Montes de Oca; María Encarnación Rodriguez-Ortiz; Juan M Diaz-Tocados; Antonio Canalejo; Mónica Florio; Ignacio López; William G Richards; Mariano Rodriguez; Escolástico Aguilera-Tejero; Juan R Muñoz-Castañeda
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.

Authors:  Serena Cappato; Laura Tonachini; Francesca Giacopelli; Mario Tirone; Luis J V Galietta; Martina Sormani; Anna Giovenzana; Antonello E Spinelli; Barbara Canciani; Silvia Brunelli; Roberto Ravazzolo; Renata Bocciardi
Journal:  Dis Model Mech       Date:  2016-04-28       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.